What milestone will Neuralink's N1 implant achieve in human-machine interface by 2025?
Achieves full sensory feedback • 25%
Enables multi-device control • 25%
Significant AI integration • 25%
Other • 25%
Official Neuralink announcements, technology conferences, and media coverage
Neuralink's Coin-Sized N1 Implant with 1,024 Electrodes Enables Thought-Controlled Computing at 9.5 BPS
Dec 14, 2024, 11:25 PM
Neuralink's N1 implant is being hailed as a groundbreaking advancement in brain-computer interface technology. The device, which is the size of a coin, features 1,024 ultra-thin electrodes that can read neural signals, allowing individuals with paralysis to control computers, play games, and type through thought alone. With a bandwidth of 9.5 bits per second, the N1 device achieves approximately 50% of normal human capability. The technology is positioned as a significant step forward in merging human cognition with machines, with potential applications in technology, medicine, and human evolution. Neuralink's recent developments have garnered attention, particularly in light of its FDA milestones and the ongoing discussions surrounding its impact on enhancing human potential.
View original story
Enhanced mobility for ALS patients • 25%
Improved communication for paralyzed patients • 25%
New treatment for epilepsy • 25%
Other significant milestone • 25%
Other • 25%
Restoration of hand movement • 25%
Improvement in speech • 25%
Restoration of leg movement • 25%
Increased electrode count • 25%
Other major update • 25%
New software features • 25%
Extended battery life • 25%
Gaming • 25%
Other • 25%
Augmented Reality • 25%
Virtual Reality • 25%
ALS treatment • 25%
Other breakthrough • 25%
Blindness treatment • 25%
Paralysis treatment • 25%
More than 30 • 25%
26 to 30 • 25%
Fewer than 20 • 25%
20 to 25 • 25%
Parkinson's disease • 25%
Depression • 25%
Other condition • 25%
Epilepsy • 25%
Case study on paralysis treatment • 25%
No high-profile case study • 25%
Case study on other neurological conditions • 25%
Case study on ALS treatment • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Gaming • 25%
Other • 25%
Medical rehabilitation • 25%
Communication • 25%